Info
AE_ALIMTA
**explain the AEs of premetrexed, such as myelosuppression, neutropenic fever, HFS, mucositis, diarrhea, nausea/vomting, transient Abn LFTs 1015%, and fatigue
**explain necessary for folic acid supplement 350ug/day and 1000ug of vitamin B12 SC Q3W
**explain the AEs of carboplatin, such as myelosuppression which is dose-limiting, especially in elder patients, thrombocytopenia is most commonly observed, nausea and vomiting, less renal toxicity as compared to cisplatin, peripheral neuropathy < 10% and less as compared to cisplatin, and hypersensitivity
**explain the AEs of cisplatin, such as nephrotoxicity, dose limiting up to 3540%, electrlyte abnormalites (Mg, Ca, K), nausea/vomting, myelosuppresion, neurotoxicity, ototoxicity, and hypersensitivity
**Emphasize the importance of nutrional support (high protein diet) during C/T period.
Siblings
- AE_ABVD
- AE_ACT
- AE_ALECTINIB
- AE_ALIMTA
- AE_ALPELISIB
- AE_BENDAMUSTINE
- AE_CCRT
- AE_CDK46
- AE_CRIZOINIB
- AE_DABRAFENIB
- AE_ENHERTU
- AE_ERIBULIN
- AE_FOLFOX
- AE_GLIVEC
- AE_HERCEPTIN
- AE_LANREOTIDE
- AE_LAPATINIB
- AE_LAR
- AE_LETROZOLE
- AE_OLAPARIB
- AE_OSIMERTINIB
- AE_PAZOPANIB
- AE_PEMIGATINIB
- AE_PERTUZUMAB
- AE_RAMUCIRUMAB
- AE_RECTAL
- AE_REGORAFENIB
- AE_SORAFENIB
- AE_SUNITINIB
- AE_TAS102
- AE_TAXOTERECDDP
- AE_TOPOTECAN
- AE_UFT
- AE_VEMURAFENIB
- AE_VINORELBINE
- AE_XELOX